Treatment of Indigestion by Unani medicine Jawarish Pudina Wilayati
- Conditions
- Functional dyspepsia,
- Registration Number
- CTRI/2020/02/023637
- Lead Sponsor
- Central Council for Research in Unani Medicine CCRUM New Delhi
- Brief Summary
This study is designed as a multicentric open trial in patients with **Su’ al-Hadm (Dyspepsia)****.** After screening, Patients will be enrolled if they satisfy inclusion and exclusion criteria. The patients will be treated with Unani pharmacopoeial formulation **Jawarish Pudina Wilayati**5 gm twice daily with water for six weeks. The patients will be assessed every second week. This includes subjective assessment of general well being and physical examination . The total duration of treatment will be two years. Laboratory parameters for safety assessment will be conducted at baseline and on completion of the protocol therapy.
**Composition of****Jawarish Pudina Wilayati**
| | | | |
| --- | --- | --- | --- |
|**S. No.**
**Ingredients**
**Botanical / Scientific Name**
**Quantity**
|1.
Berg Sudab
*Ruta graveolens* Linn.
225 gm
|2.
Boora Armani
Aluminium Silicate
56 gm
|3.
Zanjabeel
*Zingiber officinale* Rosc.
230 gm
|4.
Zeera Safaid
*Cuminum cyminum*
185 gm
|5.
Zeera Siyah
*Carum carvi* Linn.
375 gm
|6.
Filfil Siyah
*Piper nigrum* Linn.
175 gm
|7.
Agar Hindi
Aquilaria agallocha fungus
7 gm
|8.
Ilaichi Khurd
*Elettaria cardamomum*Maton.
7 gm
|9.
Ilaichi Kalan
*Amomum subulatum* Roxb.
7 gm
|10.
Pudina Khushk
*Mentha arvensis* Linn*.*
7 gm
|11.
Taj Qalmi
*Cinnamomum tamala*
7 gm
|12.
Jaiphal
*Myristica fragrans*
7 gm
|13.
Qaranful
*Syzygium aromaticum*Linn.
7 gm
|14.
Anardana
*Punica granatum* Linn.
300 gm
|15.
Tamar Hindi
*Tamarindus indica* Linn.
300 gm
|16.
Maweez Munaqqa
*Vitis vinifera* Linn.
300 gm
|17.
Qand Safaid
Sugar
7.3 kg
|18.
Sirka Desi
Vinegar
450 ml
|19.
Sat Pudina
*Mentha arvensis* extract
10 gm
|20.
Sharbat Zanjabeel
*Zingiber officinale* Syrup
1.1 lit.
|21.
Aab Leemu
Lemon water
500 ml
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- All
- Target Recruitment
- 300
- Patients of either sex in the age group of 18-60 years 2.
- Patients meeting the following Rome III diagnostic criteria for post prandial distress syndrome : Symptom onset greater than 6 months prior to the diagnosis, with the following criteria fulfilled for the past 3 months: 3.
- No structural disease by upper endoscopy to explain the symptoms 4.
- At least one of the following symptoms: a.
- Bothersome postprandial fullness b.
- Early satiation c.
- Epigastric pain d.
- Epigastric burning At least one of the following: 5.
- Bothersome postprandial fullness after ordinary sized meals occurring at least several times a week 6.
- Early satiation that prevents finishing a regular meal at least several times a week.
- Patients showing alarm symptoms (weight loss, anaemia, haematemesis, melaena, dysphagia, palpable abdominal mass) 2.
- Having any systemic disease requiring long term treatment 3.
- History of surgery related with the gastrointestinal tract more than six months 4.
- Pregnancy and lactation.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in signs and symptoms of Su’ al-Hadm (Dyspepsia) Six Weeks
- Secondary Outcome Measures
Name Time Method Haematological and biochemical assessment for safety assessment Investigations will be done at baseline and end of treatment
Trial Locations
- Locations (3)
Central Research Institute of Unani Medicine (CRIUM)
🇮🇳Lucknow, UTTAR PRADESH, India
Clinical Research Unit (CRU), Meerut
🇮🇳Meerut, UTTAR PRADESH, India
Regional Research Institute of Unani Medicine (RRIUM)
🇮🇳Delhi, DELHI, India
Central Research Institute of Unani Medicine (CRIUM)🇮🇳Lucknow, UTTAR PRADESH, IndiaDr Ziaul Haq SiddiquiPrincipal investigator9450655974crium_lko@yahoo.co.in